Navigation Links
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Date:2/25/2008

PEC) scores at 20 minutes post- dose, as compared to placebo. The effectiveness of the 10 mg dose was sustained throughout the 24-hour study period, as compared to placebo.

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

Alexza has six product candidates in clinical development. Alexza's lead program, AZ-004 (Staccato loxapine) for the treatment of acute agitation in schizophrenic or bipolar disorder patients, is in Phase 3 testing. AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches has completed Phase 2 testing. AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches and AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder are in Phase 2 testing. AZ-003 (Staccato fentanyl), which is partnered with Endo Pharmaceuticals in North America, for the treatment of breakthrough pain and AZ-007 (Staccato zaleplon) for the treatment of insomnia are in Phase 1 testing. More information, including this and past press releases from Alexza is available online at http://www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding the development, therapeutic potential and safety of AZ-004, the development of the Company's product candidates, projected clinical trial enrollment and data repor
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
2. 19th Annual Piper Jaffray Health Care Conference to Webcast Alexzas Corporate Presentation
3. Alexza Elects Dr. Hal V. Barron to Its Board of Directors
4. Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America
5. Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation
6. Alexzas Corporate Presentation to be Webcast at the 10th Annual BIO CEO & Investor Conference
7. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
8. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
9. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
10. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
11. Nventa Initiates HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
(Date:12/1/2009)Dr. Kerry Solomon announced that he has joined Carolina Eyecare Physicians and has launched his redesigned website at www.DrKerrySolomon.com , which was developed by Medical Consulting Group. Dr. So
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
....,(NasdaqGS: VARI) today announced that Garry W. R...q OMX 22nd Investor Program in London on Thursday,... A live webcast of the presentation will be publi...://www.varianinc.com . Go to http://www.varianin...ay will be available to the public,from Varian, In...
... marketing research,leader in pain, announces resu...g Company Survey". The top three most appreciated...ticals, according to the 100 pain clinic,physician... most noted for,their knowledgeable, respectful an...oucher plans, and their educational resources, as ...
...Innovations, LLC, a subsidiary of Wound Management...ished case demonstrating the efficacy of their adv... The case was presented in the,November/December ...ection,Diabetic Wound Care Management on the Leadi... #1: Using Combined Treatment Modalities for Succe...
Other Biology Technology:WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 2WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 3Wound Management Technologies, Inc. Announces a Published Case Study 2Wound Management Technologies, Inc. Announces a Published Case Study 3
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Taking dex can improve high altitude exercise capacity in certain climbers 54225 1Taking dex can improve high altitude exercise capacity in certain climbers 54225 2Taking dex can improve high altitude exercise capacity in certain climbers 54225 3Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 1Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 2Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 3World Stem Cell Summit to Be Held in Baltimore 13504 1World Stem Cell Summit to Be Held in Baltimore 13504 2
...es may prevent recovering drug abusers from relaps...ve discovered., The team, led by Professor Barry E... in rats by blocking a brain chemical receptor imp... drug-associated memories. Their research, which ...ported in the 13 August issue of The Journal of N...
...2 AUGUST 2008 -- More than 10,000 international sc...ill gather at the George R. Brown Convention Cente...test research and trends in energy, water resource... earth sciences, and related disciplines. , This ... that showcases the sciences of the sponsoring org...
...performance of different types of green roofs has ... Center at The University of Texas at Austin and s...re created equal. , Interest in vegetated roofs h...mes more important to property owners. Yet the stu...the green roofs varied greatly in capabilities suc...
Other Biology News:'Erasing' drug-associated memories may stop drug addiction relapses 2Scientists team up in Houston to tackle global challenges 2Scientists team up in Houston to tackle global challenges 3Scientists team up in Houston to tackle global challenges 4Green roofs differ in building cooling, water handling capabilities 2Green roofs differ in building cooling, water handling capabilities 3
...ntials Kit provides all the necessary materials an...n washing of the mir Vana miRNA Bioarrays when us...g Ambions mir Vana miRNA Labeling Kit. The kit al...BA10001) that should be spiked into your miRNA pre...
...ellular Localization Kit provides a straight forwa...f your design, in an efficient yet non-destructive...lular localization and functional inhibition of ta...troduction of the labeled siRNA into mammalian cel...
...ellular Localization Kit provides a straight forwa...f your design, in an efficient yet non-destructive...lular localization and functional inhibition of ta...troduction of the labeled siRNA into mammalian cel...
...ellular Localization Kit with TransIT-siQUEST Tran...ach to directly label and deliver siRNA, of your d... for in vitro tracking experiments. Subcellular lo...e expression can be monitored following introducti...
Biology Products: